Fibrinolytic activity and the effects of beta-pyridylcarbinol (Ronicol) in patients with arteriosclerosis obliterans. 1983

L Grodzińska, and M Basista, and A Kedzior, and R Korbut, and E Kostka-Trabka, and R Gryglewski

Twenty-one patients with arteriosclerosis obliterans of lower extremities were treated with beta-pyridylcarbinol (Ronicol) for five weeks. The long-term therapy with beta-pyridylcarbinol did not influence platelet aggregability. Activation of the fibrinolytic system was observed. This fibrinolytic effect of Ronicol was abolished in patients treated with aspirin. In most cases a slight clinical improvement was seen, manifested by elongation of pain-free walking distance and increased blood flow in affected limbs. It is concluded that the therapeutic effect of Ronicol in humans may be partly mediated by the release of endogenous prostacyclin.

UI MeSH Term Description Entries
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001162 Arteriosclerosis Obliterans Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION. Obliterans, Arteriosclerosis
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

L Grodzińska, and M Basista, and A Kedzior, and R Korbut, and E Kostka-Trabka, and R Gryglewski
April 1983, Pharmacological research communications,
L Grodzińska, and M Basista, and A Kedzior, and R Korbut, and E Kostka-Trabka, and R Gryglewski
June 1949, Schweizerische medizinische Wochenschrift,
L Grodzińska, and M Basista, and A Kedzior, and R Korbut, and E Kostka-Trabka, and R Gryglewski
June 1949, Schweizerische medizinische Wochenschrift,
L Grodzińska, and M Basista, and A Kedzior, and R Korbut, and E Kostka-Trabka, and R Gryglewski
January 1949, Helvetica physiologica et pharmacologica acta,
L Grodzińska, and M Basista, and A Kedzior, and R Korbut, and E Kostka-Trabka, and R Gryglewski
April 1982, Thrombosis and haemostasis,
L Grodzińska, and M Basista, and A Kedzior, and R Korbut, and E Kostka-Trabka, and R Gryglewski
January 1989, Acta physiologica Hungarica,
L Grodzińska, and M Basista, and A Kedzior, and R Korbut, and E Kostka-Trabka, and R Gryglewski
June 1949, Schweizerische medizinische Wochenschrift,
L Grodzińska, and M Basista, and A Kedzior, and R Korbut, and E Kostka-Trabka, and R Gryglewski
June 1982, Pharmacological research communications,
L Grodzińska, and M Basista, and A Kedzior, and R Korbut, and E Kostka-Trabka, and R Gryglewski
January 1974, Atherosclerosis,
L Grodzińska, and M Basista, and A Kedzior, and R Korbut, and E Kostka-Trabka, and R Gryglewski
February 1955, Munchener medizinische Wochenschrift (1950),
Copied contents to your clipboard!